NFSG
RPRX icon

Newbridge Financial Services Group’s Royalty Pharma RPRX Stock Holding History

Newbridge Financial Services Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50
Closed -$1.36K – 1301
2023
Q3 		$1.36K Hold
50
– – ﹤0.01% 1128
2023
Q2 		$1.54K Hold
50
– – ﹤0.01% 1168
2023
Q1 		$1.8K Hold
50
– – ﹤0.01% 1210
2022
Q4 		$1.98K Hold
50
– – ﹤0.01% 1216
2022
Q3 		$2K Hold
50
– – ﹤0.01% 1229
2022
Q2 		$2K Hold
50
– – ﹤0.01% 1214
2022
Q1 		$2K Hold
50
– – ﹤0.01% 1319
2021
Q4 		$2K Hold
50
– – ﹤0.01% 1267
2021
Q3 		$2K Hold
50
– – ﹤0.01% 1197
2021
Q2 		$2K Hold
50
– – ﹤0.01% 1294
2021
Q1 		$2K Buy
+50
New +$2.37K ﹤0.01% 1191

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Newbridge Financial Services Group's RPRX Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Royalty Pharma (RPRX) in Q4 2023, closing a stake of 50 shares — an estimated $1.36K sold.

Newbridge Financial Services Group first reported a position in RPRX in Q1 2021 and held it in 11 quarters. The position peaked at $2K in Q3 2022. 363 funds tracked by Wall St. Rank hold RPRX as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Royalty Pharma position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 50 Royalty Pharma shares in Q4 2023, an estimated $1.36K.
  • Newbridge Financial Services Group first reported a position in Royalty Pharma in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's Royalty Pharma position peaked at $2K in Q3 2022.
  • 363 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.